These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28797715)

  • 21. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.
    Kidambi TD; Blanco A; Myers M; Conrad P; Loranger K; Terdiman JP
    Dig Dis Sci; 2015 Aug; 60(8):2463-9. PubMed ID: 24903654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
    Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
    Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
    Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
    Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lynch syndrome and urologic malignancies: a contemporary review.
    Lim A; Rao P; Matin SF
    Curr Opin Urol; 2019 Jul; 29(4):357-363. PubMed ID: 31045926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
    Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
    J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for Lynch syndrome in the province of Ontario.
    Wang M; Aldubayan S; Connor AA; Wong B; Mcnamara K; Khan T; Semotiuk K; Khalouei S; Holter S; Aronson M; Cohen Z; Gallinger S; Charames G; Pollett A; Lerner-Ellis J
    Cancer; 2016 Jun; 122(11):1672-9. PubMed ID: 27019099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to Lynch Syndrome for the Gastroenterologist.
    Bui QM; Lin D; Ho W
    Dig Dis Sci; 2017 Feb; 62(2):299-304. PubMed ID: 27990589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Lynch syndrome: we are all responsible.
    Sanchez JA; Vogel JD; Kalady MF; Bronner MP; Skacel M; Church JM
    Dis Colon Rectum; 2008 Dec; 51(12):1750-6. PubMed ID: 18682882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Screening of Upper Tract Urothelial Carcinomas for Lynch Syndrome Diagnostics: A Systematic Review.
    Rasmussen M; Madsen MG; Therkildsen C
    Urology; 2022 Jul; 165():44-53. PubMed ID: 35217028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
    Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ
    Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lynch syndrome and MYH-associated polyposis: review and testing strategy.
    Goodenberger M; Lindor NM
    J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.
    Bruegl AS; Ring KL; Daniels M; Fellman BM; Urbauer DL; Broaddus RR
    Cancer Prev Res (Phila); 2017 Feb; 10(2):108-115. PubMed ID: 27965287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
    Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
    Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology.
    Cohen SA; Pritchard CC; Jarvik GP
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():293-307. PubMed ID: 30848956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.